Ledger.Open graph →
SEC Form D · filed December 6, 2017

Intiva BioPharma Inc

Offering
$1.4M
Sold
$1.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
GLENDALE, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Evan Wasoff · Glendale, COExecRichard Greenberg · Glendale, COExec · DirectorRobert Goldfarb · Glendale, COExecAlain Bankier · Glendale, CODirectorJeffrey Friedland · Glendale, COExec · DirectorRandolph Seidler · Wiesbaden, 2MExec · DirectorJohn L. Mallinson · New York, NYExecPeter Longo · Rocky Hill, CTDirectorPer G. Lindberg · Stockholm, V7Exec · DirectorRodrigo Bicalho · Dryden, NYExec · DirectorDesiree D. Storch · Truckee, CADirectorDavid D. Scacco · Truckee, CAExec · DirectorSpencer Thompson · New York, NYExecJonathan N. Hoke · Somerville, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗